Massachusetts General Hospital Oncology Dept — Boston, Massachusetts

Massachusetts General Hospital Oncology Dept is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Oncology Dept has participated in 1 clinical trials.

Therapeutic areas: Hepatocellular Carcinoma (HCC), Solid Malignancies.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Oncology Dept?

Massachusetts General Hospital Oncology Dept has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Oncology Dept conducted?

Massachusetts General Hospital Oncology Dept has 1 clinical trials on record. Their work covers Hepatocellular Carcinoma (HCC), Solid Malignancies.

Is Massachusetts General Hospital Oncology Dept accredited by Crixeo Health?

Massachusetts General Hospital Oncology Dept has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Oncology Dept?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.